Use outside of clinical trials or approved indications is illegal in many jurisdictions
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO).
Compared to traditional antidiabetic drugs, GLP-1 RAs showed no statistically significant differences in nasopharyngitis, headache, lipase increased and dyspepsia while showed higher risk of nausea and vomiting
It was one of the first synthetic GH-releasing peptides characterized, containing D-tryptophan at position 2 and D-phenylalanine at position 5
Benefits include: \Musculoskeletal Repair: May support faster healing of tendons, ligaments, muscle, and bone (Animal Study)
Albiglutide was discontinued for low prescription rates rather than safety concerns [70, 71]